Abstract
In the present study we investigate the behavioural effects of β-asarone, the main compound of the essential oil obtained from Acorus calamus. β-asarone, when administered intraperitoneally in rats, exerts sedative and hypothermic but not analgesic effects. β-asarone, however, when administered in association with the cannabinomimetic drug WIN 55,212-2, was shown to potentiate some of the typical behavioural activities induced in animals by cannabinoids. Binding assays, performed on cortical synaptic membrane preparations using a specific cannabinoid radioligand ([3H]CP-55,940), excluded the ability of β-asarone to exert a direct agonistic activity on CB1 receptors. Hence, β-asarone cannot be considered a pure cannabinomimetic agent but it can be envisaged at least as an allosteric modulatory agent. © 1998 John Wiley & Sons, Ltd.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.